COVID-19 Vaccine - en | Covid19.go.id

About COVID-19 Vaccine

Lawan Covid19

What is Vaccination

Vaccination is the administration of vaccines in order to actively generate or increase a person's immunity against a disease, so that if one day they are exposed to the disease, they will not get sick or only experience mild illness and will not become a source of transmission.

COVID-19 vaccination services are carried out at Health Service Facilities owned by the Central Government, Provincial Governments, Regency/City Governments or owned by the public/private sector that meet the requirements, including:

  • Puskesmas, Puskesmas Pembantu
  • Clinic
  • Hospital and/or
  • Health Service Unit at the Port Health Office (KKP)
Or Check Here
District/City Health Offices and Puskesmas can also establish COVID-19 vaccination service posts. It is recommended that each target seek information in advance regarding the service schedule of each health service facility or vaccination service post.

How can Vaccines work in the body to protect us?

  • Vaccines are biological products that are given to a person to protect him or her from a debilitating, even life-threatening disease.
  • Vaccines will stimulate the formation of immunity against certain diseases in a person's body.
  • The body will remember the virus or disease-causing bacteria, recognize and know how to fight it.
Lawan Covid19

List of COVID-19 Vaccines Used in Indonesia

In the implementation of the COVID-19 vaccination program in Indonesia, the government strives for the availability of vaccines to be fulfilled for at least 208,265,720 of the population to achieve group immunity.

These vaccine procurement efforts are carried out through bilateral agreements and multilateral agreements such as the COVAX Facility with GAVI and WHO, or donations provided by friendly countries.

The Indonesian Food and Drug Administration has granted emergency use permits for 10 types of COVID-19 vaccines, namely Sinovac, AstraZeneca, Sinopharm, Moderna, Pfizer, Novavax, Sputnik-V, Janssen, Convidencia, and Zifivax.

Each of these types of vaccines has a mechanism for its own administration, from the number of doses, the interval of administration, to different vaccine platforms, namely inactivated virus, RNA-based, viral-vector, and protein sub-units.

*The vaccines provided are vaccines that have been confirmed to be safe and effective.

SINOVAC VACCINE
COVID-19 Vaccine (Vero Cell) Inactivated, CoronaVac® is an inactivated vaccine against COVID-19 that stimulates the immune system without the risk of causing disease. Once this inactivated vaccine comes into contact with the immune system, antibody production is stimulated, so the body is ready to respond to infection with live SARS-CoV-2. This vaccine contains an adjuvant (aluminum hydroxide), to strengthen the immune system response.
The ChAdOx1-S/nCoV-19 vaccine is a non-replicating adenovirus vector vaccine for COVID-19. The vaccine expresses the SARS-CoV-2 spike protein gene, which instructs the host cell to produce an S-antigen protein unique to SARS-CoV-2, so that the body can generate an immune response and store that information in memory immune cells. Efficacy in clinical trials in participants who received the full course of the vaccine (two doses) in the UK, Brazil, and South Africa regardless of the dose interval was 61%, with a median follow-up period of 80 days, but tends to be higher if this interval is longer. . Additional data from interim analyzes of clinical trials in the United States showed a vaccine efficacy of 76% against symptomatic SARS-CoV-2 infection.
Moderna's COVID-19 vaccine is a messenger RNA (mRNA) based vaccine for COVID-19. The host cell receives instructions from the mRNA to produce the unique S-antigen protein SARS-CoV-2, so that the body can generate an immune response and store that information in memory immune cells. Efficacy according to clinical trials in participants who received the full dose of this vaccine (two doses) and had an initial SARS-CoV-2 negative status was approximately 94% with a median follow-up period of nine weeks. All data reviewed support the conclusion that the known and potential benefits of the mRNA-1273 vaccine outweigh the known and potential risks.
The SARS-CoV-2 Vaccine (Vero Cell) is an inactivated vaccine against COVID-19 that stimulates the immune system without the risk of causing disease. Once this inactivated vaccine comes into contact with the immune system, antibody production is stimulated, so the body is ready to respond to infection with live SARS-CoV-2. This vaccine contains an adjuvant (aluminum hydroxide), to strengthen the immune system response. A large phase 3 clinical trial demonstrated that two doses at 21-day intervals had 79% efficacy against symptomatic SARS-CoV-2 infection 14 days or more after the second dose. These clinical trials are neither designed nor robust enough to demonstrate efficacy against severe disease.
COMIRNATY® is a messenger RNA (mRNA) based vaccine for COVID-19. The mRNA instructs the cell to produce an S-antigen protein (part of the spike protein) unique to SARS-CoV-2 to stimulate an immune response. In clinical trials, efficacy in participants with or without evidence of previous SARS-CoV-2 infection and who received the full dose of this vaccine (two doses) was estimated at 95% with a median follow-up period of two months.

Question and Answer

The general public over 18 years old can check tickets and start vaccination schedules on the PeduliLindungi website and application. The ticket can be used at the nearest health facility or vaccination center at the scheduled start of the third vaccination (at least 3 months after the second dose of vaccination).

Through the website, the public can visit pedulilindungi.id and check the status and vaccination tickets by entering “Full Name” and “NIK”, then click check. If through the PeduliLindung application, the public can follow these steps:

  • Open the PeduliLindungi application
  • Login with registered account
  • Click the "Profile" menu and select "Vaccination Status & Covid-19 Test Results"
  • The booster vaccination status and schedule will appear in your account
  • To check tickets, go to the menu "History and Vaccine Tickets"

Everyone has the right to get a booster vaccine. However, for the first stage, booster vaccination for the general public is intended for the elderly (elderly) and vulnerable groups (immunocompromised patients).

source: Kemenkes

The combination of booster vaccines currently being given is based on the considerations of domestic and foreign researchers and has been confirmed by the POM and ITAGI, including:

  • For targets with the primary vaccine, Sinovac can be given half the dose of Astra Zeneca (0.25 ml), or half the dose of Pfizer (0.15 ml), or the full dose of Moderna (0.5 ml), or the full dose of Sinopharm (0.5 ml). dose), or the full dose of Sinovac (0.5 ml), or the full dose of Zifivax (0.5 ml)
  • For targets with the primary Astra Zeneca vaccine, the full dose of Astra Zeneca (0.5 ml), or half the dose of Pfizer (0.15 ml), or half the dose of Moderna (0.25 ml) can be given.
  • For targets with the Pfizer primary vaccine, the full dose of Pfizer (0.3 ml), or the half dose of Moderna (0.25 ml), or the full dose of Astra Zeneca (0.5 ml) can be given.
  • For targets with the Moderna primary vaccine can be given half the dose of Moderna (0.25 ml)
  • For targets with the Janssen primary vaccine (J&) can be given half the dose of Moderna (0.25 ml)
  • For targets with the primary Sinopharm vaccine, the full dose of Sinopharm (0.5 ml) or the full dose of Zifivax (0.5 ml) can be given.

If there is a new follow-up dose regimen, it will be delivered later.

*Policy development 28 May 2022

Can not. The schedule listed in the PeduliLindung application has been adjusted to government regulations that require a minimum of 3 months from the second dose.

source: Ministry of Health

The public cannot choose the type of booster vaccination. The type of booster has been determined according to the regimen determined by the Government and can be accessed here.. The type of vaccine will be determined by the health worker based on the history of vaccine doses 1 and 2 as well as the availability of the vaccine at the service site.

source: Ministry of Health

How to check vaccination certificate in PeduliLindungi?

Have you been vaccinated? There is now an easy way to check vaccine certificates.

Checking vaccine certificates with NIK is very easy and fast. You can immediately know the status of your vaccine certificate. Here are the steps:

  1. Go to https://pedulilindungi.id
  2. Fill in your full name and the required population identification number (NIK)
  3. Check the captcha field "I'm not a robot"
  4. Click "Check" and the COVID-19 vaccine status will appear.

If you have been vaccinated, the vaccine certificate will automatically be loaded in the system. But if not, you can wait 7-10 days after the vaccine.

If the certificate is not available, contact CALL CENTER 119 with extension 9 for assistance.

Remember, don't share your data or vaccination certificate carelessly or publicly because there is a lot of valuable personal data there that can be misused by irresponsible parties.

Important Info